Andrew R Allen's Net Worth

$13.5 Million

Who is Andrew R Allen?

Andrew R Allen has an estimated net worth of $13.5 Million. This is based on reported shares across multiple companies, which include Gritstone bio, Inc., PHARMION CORP, Sierra Oncology, Inc., Clovis Oncology, Inc., TCR2 THERAPEUTICS INC., Epizyme, Inc., and Adaptimmune Therapeutics PLC.

SEC CIK

Andrew R Allen's CIK is 0001374539

Past Insider Trading and Trends

2023 was Andrew R Allen's most active year for acquiring shares with 8 total transactions. Andrew R Allen's most active month to acquire stocks was the month of February. 2008 was Andrew R Allen's most active year for disposing of shares, totalling 11 transactions. Andrew R Allen's most active month to dispose stocks was the month of February. 2008 saw Andrew R Allen paying a total of $297,891.58 for 4,113 shares, this is the most they've acquired in one year. In 2015 Andrew R Allen cashed out on 160,000 shares for a total of $10,521,188.32, their largest year based on trade value.